Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs A Systematic Review and Meta-Analysis

被引:143
|
作者
Kesselheim, Aaron S. [1 ,2 ]
Stedman, Margaret R. [1 ,2 ]
Bubrick, Ellen J. [2 ,3 ]
Gagne, Joshua J. [1 ,2 ]
Misono, Alexander S. [1 ,2 ]
Lee, Joy L. [1 ,2 ]
Brookhart, M. Alan [4 ]
Avorn, Jerry [1 ,2 ]
Shrank, William H. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Neurol, Div Epilepsy, Boston, MA 02115 USA
[4] UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
基金
美国医疗保健研究与质量局;
关键词
SUBSTITUTION; BIOAVAILABILITY; CARBAMAZEPINE; EPILEPSY; DISSOLUTION; IDENTIFICATION; LAMOTRIGINE; MEDICATION; PATIENT; EVENTS;
D O I
10.2165/10898530-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The automatic substitution of bioequivalent generics for brand-name antiepileptic drugs (AEDs) has been linked by anecdotal reports to loss of seizure control. Objective: To evaluate studies comparing brand-name and generic AEDs, and determine whether evidence exists of superiority of the brand-name version in maintaining seizure control. Data Sources: English-language human studies identified in searches of MEDLINE, EM BASE and International Pharmaceutical Abstracts (1984 to 2009). Study Selection: Randomized controlled trials (RCTs) and observational studies comparing seizure events or seizure-related outcomes between one brand-name AED and at least one alternative version produced by a distinct manufacturer. Data Extraction: We identified 16 articles (9 RCTs, 1 prospective non-randomized trial, 6 observational studies). We assessed characteristics of the studies and, for RCTs, extracted counts for patients whose seizures were characterized as 'controlled' and 'uncontrolled'. Data Synthesis: Seven RCTs were included in the meta-analysis. The aggregate odds ratio (n = 204) was 1.1(95% CI 0.9, 1.2), indicating no difference in the odds of uncontrolled seizure for patients on generic medications compared with patients on brand-name medications. In contrast, the observational studies identified trends in drug or health services utilization that the authors attributed to changes in seizure control. Conclusions: Although most RCTs were short-term evaluations, the available evidence does not suggest an association between loss of seizure control and generic substitution of at least three types of AEDs. The observational study data may be explained by factors such as undue concern from patients or physicians about the effectiveness of generic AEDs after a recent switch. In the absence of better data, physicians may want to consider more intensive monitoring of high-risk patients taking AEDs when any switch occurs.
引用
收藏
页码:605 / 621
页数:17
相关论文
共 50 条
  • [31] Ifosfamide-induced neurotoxicity, brand-name versus generic formulation: a review of the French Pharmacovigilance Database
    Chenaf, C.
    Barthelemi, L.
    Descoeur, J.
    Fournier-Choma, C.
    Hillaire-Buys, D.
    Zenut, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 40 - 40
  • [32] Phenytoin versus other antiepileptic drugs as treatments for status epilepticus in adults: a systematic review and meta-analysis
    Hoshiyama, Eisei
    Kumasawa, Junji
    Uchida, Masatoshi
    Hifumi, Toru
    Moriya, Takashi
    Ajimi, Yasuhiko
    Miyake, Yasufumi
    Kondo, Yutaka
    Yokobori, Shoji
    ACUTE MEDICINE & SURGERY, 2022, 9 (01):
  • [33] Seizure Outcomes Following Radiosurgery for Cerebral Arteriovenous Malformations: An Updated Systematic Review and Meta-Analysis
    Ironside, Natasha
    Chen, Ching-Jen
    Ding, Dale
    Ilyas, Adeel
    Kumar, Jeyan
    Buell, Thomas
    Taylor, Davis
    Lee, Cheng-Chia
    Sheehan, Jason
    JOURNAL OF NEUROSURGERY, 2019, 131 (01)
  • [34] Long-term seizure outcomes following epilepsy surgery:: a systematic review and meta-analysis
    Téllez-Zenteno, JF
    Dhar, R
    Wiebe, S
    BRAIN, 2005, 128 : 1188 - 1198
  • [35] No Significant Outcome Benefit for Brand-Name Versus Generic Tacrolimus in Kidney Transplant Recipients: SRTR Analysis
    Goldfarb, D.
    Poggio, E.
    Flechner, S.
    Fatica, R.
    Schold, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] Use of antiepileptic drugs as prophylaxis against posttraumatic seizures in the pediatric population: a systematic review and meta-analysis
    Samara, Qais A.
    Ifraitekh, Ali S.
    Al Jayyousi, Obada
    Sawan, Siya
    Hazaimeh, Ethar
    Jbarah, Omar F.
    NEUROSURGICAL REVIEW, 2023, 46 (01)
  • [37] Use of antiepileptic drugs as prophylaxis against posttraumatic seizures in the pediatric population: a systematic review and meta-analysis
    Qais A. Samara
    Ali S. Ifraitekh
    Obada Al Jayyousi
    Siya Sawan
    Ethar Hazaimeh
    Omar F. Jbarah
    Neurosurgical Review, 46
  • [38] Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis
    Keskin-Arslan, Elif
    Erol, Hilal
    Uysal, Nusrel
    Karadas, Baris
    Temiz, Tijen
    Kaplan, Yusuf Cem
    REPRODUCTIVE TOXICOLOGY, 2023, 115 : 124 - 146
  • [39] A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs
    Lotufo, Paulo A.
    Valiengo, Leandro
    Bensenor, Isabela M.
    Brunoni, Andre R.
    EPILEPSIA, 2012, 53 (02) : 272 - 282
  • [40] Impact of antiepileptic drugs for seizure prophylaxis on short and long-term functional outcomes in patients with acute intracerebral hemorrhage: A meta-analysis and systematic review
    Spoelhof, Brian
    Sanchez-Bautista, Julian
    Zorrilla-Vaca, Andres
    Kaplan, Peter W.
    Farrokh, Salia
    Mirski, Marek
    Freund, Brin
    Rivera-Lara, Lucia
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 69 : 140 - 146